M. Wijsenbeek

Erasmus Medical Center

Poster Author Of 5 e-Posters

 ePosters
12. Diffuse Parenchymal Lung Diseases: ILD, Sarcoidosis, IPF, LAM

A2636 - Long-Term Safety and Efficacy of Recombinant Human Pentraxin-2 in Patients with Idiopathic Pulmonary Fibrosis

Presenter:
Date
05/20/2019
Room
Room C155-C156 (Level 1), KBHCCD
Session Name
B17 - ADVANCES IN ILD THERAPY
Session Type
Mini Symposium
Authors
12. Diffuse Parenchymal Lung Diseases: ILD, Sarcoidosis, IPF, LAM

A4088 - Health-Related Quality of Life in Patients with IPF Treated with Nintedanib: Stratified Analysis from the INPULSIS® Trials

Presenter:
Date
05/20/2019
Room
Room C140/C142 (Level 1), KBHCCD
Session Name
B103 - ILD: THERAPY
Session Type
RAPiD: Rapid Abstract Poster Discussion Session
Authors
12. Diffuse Parenchymal Lung Diseases: ILD, Sarcoidosis, IPF, LAM

A4328 - Diagnostic Delays in Interstitial Lung Diseases (ILDs)

Presenter:
Date
05/21/2019
Room
Room C140/C142 (Level 1), KBHCCD
Session Name
C22 - ILD: DIAGNOSIS
Session Type
Poster Discussion Session
Authors
12. Diffuse Parenchymal Lung Diseases: ILD, Sarcoidosis, IPF, LAM

A4597 - Rationale, Design and Objectives of Two Phase III, Randomised, Placebo-Controlled Studies of GLPG1690, a Novel Autotaxin Inhibitor, in Idiopathic Pulmonary Fibrosis (ISABELA 1 and 2)

Presenter:
Date
05/21/2019
Room
Area H (Hall F, Level 2), KBHCCD
Session Name
C34 - ILD AND IPF: CLINICAL AND MECHANISTIC STUDIES
Session Type
Thematic Poster Session
Authors
27. Right Ventricular and Pulmonary Vasculature, Health and Disease

A5081 - Impact of Parenchymal Lung Disease in Echocardiographic Estimate of Pulmonary Artery Pressure in Sarcoidosis Patients

Presenter:
Date
05/21/2019
Room
Area J (Hall F, Level 2), KBHCCD
Session Name
C52 - USE YOUR ILLUSION II: CLINICAL RESEARCH IN PAH
Session Type
Thematic Poster Session
Authors